Oxford Nanopore opens new bioinformatics shop

With an eye toward recruiting top brains in informatics, Oxford Nanopore Technologies says that it has opened a new hub in Cambridge, U.K. The developer of DNA sequencers has also expanded its presence in its home base of Oxford, U.K.

The deal comes about three months after Oxford Nanopore--which is advancing a system for electronic analysis of single molecules and DNA sequencing--raised £25 million in a financing. With the capital infusion, the life sciences firm aims to recruit around 20 new staffers for both its Oxford and Cambridge operations, BusinessWeekly reported.

"The Cambridge location helps us to attract the best informaticians," said Gordon Sanghera, the 6-year-old company's CEO. "Because the European informatics community has such strong links to Cambridge, we believe it will be critical to have a facility there to support our current and future informatics staff."

Cambridge is already home to some of the U.K.'s top life sciences operations. As BusinessWeekly reports, Oxford Nanopore is moving into the Chestford Research Park, which already houses an outpost of drug giant Pfizer as well as R&D firm BioFocus and younger outfits such as Cellzome and Isogenica.

- here's the release
- check out BusinessWeekly's report

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.